Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Bedford-based Insulet Corp. (Nasdaq: PODD) has received 510(k) clearance from the U.S. Food and Drug Administration for a new insulin pump that?s smaller and lighter than its current product.
The new OmniPod insulin pump is more than one-third smaller and one-quarter lighter than the original model, which was introduced in 2005, according to the company. Insulet expects the first shipments of the new device to come to the U.S. around March, and plans to convert current users of the device to the new one.
http://www.bizjournals.com/boston/blog/bioflash/2012/12/insulet-gets-fda-ok-on-smaller-insulin.html
The new OmniPod insulin pump is more than one-third smaller and one-quarter lighter than the original model, which was introduced in 2005, according to the company. Insulet expects the first shipments of the new device to come to the U.S. around March, and plans to convert current users of the device to the new one.
http://www.bizjournals.com/boston/blog/bioflash/2012/12/insulet-gets-fda-ok-on-smaller-insulin.html